Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001104659-22-064838

Chief Executive Officer acquired 21,135 shares (other)

From the SEC's structured data for this filing

Trades in this filing

DUGGAN ROBERT W · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-23 Other acquisition : show line 1 in the form +21,135 67,683,589 D
Loading xslF345X03/tm2216975-1_4seq1.xml…